{"id":"W2255518001","doi":"10.1016/s0140-6736(15)01088-0","title":"Antiangiogenic therapy in oncology: current status and future directions","year":2016,"lang":"en","type":"review","venue":"The Lancet","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":836,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Wellbeing of Women; National Institute for Health and Care Research; Cancer Research UK; F. Hoffmann-La Roche; AstraZeneca","keywords":"Medicine; Oncology; Angiogenesis; Internal medicine; Pancreatic cancer; Clinical trial; Vascular endothelial growth factor; Prostate cancer; Cancer; VEGF receptors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04919243220325039,"score_gpt":0.3708595586706583,"score_spread":0.3216671264674079,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}